Randomized proof from medical trials and naturalistic proof gathered from pharmacoepidemiology and pharmacovigilance routines each contribute to the Original and steady assessment of your benefits and risks of the drug, ie, the balance concerning therapeutic efficacy and basic safety risks. Benefit-risk assessment (BRA) generally depends over a qua